Zeda Opens Advanced Manufacturing Digital Foundry in Cincinnati, Ohio

3 years ago

Zeda Opens Advanced Manufacturing Digital Foundry in Cincinnati, Ohio Steve Rengers, Senior Vice President of Zeda, Inc. at the new…

The Belgian Brand Using Maca Root to Naturally Boost Libido

3 years ago

Male Plus’s Unique Formula Utilizes Natural Ingredients to Stimulate Sexual Desire. One of These Is Maca Root.Fort Lauderdale, FL, May…

Male Plus Is Enhancing Men’s Libidos By Destressing Their Minds

3 years ago

The Brand’s Natural Formula Stimulates the Body While Calming the Mind, Making It Easier to Get in the MoodFort Lauderdale,…

Aerami Therapeutics Announces Pharmacokinetic Data Demonstrating the Potential of AER-901 (Inhaled Imatinib) to Achieve Therapeutic Levels at Low Inhaled Doses for Treatment of Pulmonary Hypertension

3 years ago

DURHAM, N.C., May 24, 2023 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life…

Palisade Bio’s LB1148 Two Ongoing Clinical Trials Expecting Topline Data Readouts

3 years ago

Company approaching Phase 2 topline data readout for prevention of post-surgical abdominal adhesions Continued momentum with execution of ongoing dose…

Smart for Life Announces Launch of New Line of Sports Illustrated Protein Bars

3 years ago

Sports Illustrated Protein Bars Are Specifically Engineered to Promote Clean and Active Lifestyles Smart for Life Launches New Line of…

Biodexa Pharmaceuticals PLC Announces US$3.32 Million Registered Direct Offering

3 years ago

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO CANADA, AUSTRALIA, JAPAN…

Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock

3 years ago

MALVERN, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biotechnology company focused on discovering, developing, and…

Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer

3 years ago

DANBURY, Conn., May 24, 2023 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization…

Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma approved in Brazil

3 years ago

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical…